Ucb Inc

General

Total Cases126
Active Cases8
Patents444
TypeOperating Company
Elite Ratings
PTAB

Ratings

Experience
Grade
Trend
DCT
L4
A
PTAB
L4
A
CAFC
L4
D

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
07/02/24
MAILED Form AO 120 to U.S. Patent and Trademark Office. (document is sealed) (law) (Entered: 07/02/2024)
07/02/24
MAILED Form AO 120 to U.S. Patent and Trademark Office. (document is sealed) (law) (Entered: 07/02/2024)
07/02/24
CONSENT JUDGMENT. Signed by Judge Christina Reiss on 7/1/2024. (law) (Entered: 07/02/2024)
07/02/24
CONSENT JUDGMENT. Signed by Judge Christina Reiss on 7/1/2024. (law) (Entered: 07/02/2024)
06/28/24
PROPOSED CONSENT JUDGMENT by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Hoechst, Kendall) (Entered: 06/28/2024)
06/28/24
PROPOSED CONSENT JUDGMENT by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Hoechst, Kendall) (Entered: 06/28/2024)
06/26/24
STIPULATION AND ORDER to Extend Deadlines: Discovery due by 7/31/2024; Motions due by 8/21/2024; Ready for Trial by 8/21/2024. Signed by Judge Christina Reiss on 6/25/2024. (law) (Entered: 06/26/2024)
06/26/24
STIPULATION AND ORDER to Extend Deadlines: Discovery due by 7/31/2024; Motions due by 8/21/2024; Ready for Trial by 8/21/2024. Signed by Judge Christina Reiss on 6/25/2024. (law) (Entered: 06/26/2024)
06/25/24
STIPULATION and [Proposed] Order to Extend Deadlines by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Berger, Ritchie) (Entered: 06/25/2024)
06/25/24
STIPULATION and [Proposed] Order to Extend Deadlines by LTS Lohmann Therapie-Systeme AG, UCB Pharma GmbH, UCB, Inc. (Berger, Ritchie) (Entered: 06/25/2024)